Will an antipsychotic be effective for hallucinations caused by levetiracetam (Keppra) toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, antipsychotics are not the primary treatment for Keppra-induced hallucinations—the first-line approach is to reduce or discontinue levetiracetam itself.

Primary Management Strategy

The most effective intervention for levetiracetam-induced hallucinations is dose reduction or discontinuation of the offending drug 1. The FDA label explicitly documents that hallucinations occurred in Keppra-treated patients and resolved within 2-7 days while patients remained on treatment (in some cases) or within 1-2 weeks following discontinuation 1. This represents the evidence-based first-line approach.

Clinical Algorithm for Management:

Step 1: Identify and Stop the Cause

  • Immediately reduce levetiracetam dose or discontinue entirely
  • The FDA label shows hallucinations resolved in 2-7 days with continued treatment at lower doses, or 1-2 weeks after stopping 1
  • Recent research confirms this approach: symptoms were controlled by "reducing the dose of levetiracetam, stopping the drug, or adding antipsychotic drugs" 2—note that dose reduction/stopping comes before antipsychotics in the treatment hierarchy

Step 2: Consider Antipsychotics as Adjunctive Therapy Only

Antipsychotics may have a role as temporary adjunctive management while the levetiracetam is being tapered or cleared, but they do not address the root cause. The critical guideline caveat: antipsychotics can potentially worsen agitation in drug-induced toxicity states due to their anticholinergic side effects 3. The 2006 emergency medicine guideline specifically warns that "agitation may be a result of drug ingestions or poisonings...In this scenario, the antipsychotics, both conventional and atypical...can potentially exacerbate agitation because of their anticholinergic side effects" 3.

Why Antipsychotics Are Not First-Line:

  • Drug-induced hallucinations resolve with removal of the causative agent—treating the symptom without addressing the cause prolongs exposure to a toxic medication
  • Levetiracetam-induced psychiatric symptoms (including hallucinations, delusions, aggressive behavior) are well-documented adverse effects occurring in 0.7% of patients in controlled trials 1
  • Multiple case reports demonstrate complete resolution after switching to alternative antiepileptic drugs like sodium valproate 4, 5

Common Pitfalls to Avoid:

  1. Do not continue full-dose levetiracetam while treating hallucinations with antipsychotics—this treats the symptom while perpetuating the cause
  2. Do not assume psychiatric symptoms require psychiatric medication—in drug toxicity, the medication IS the problem
  3. Avoid anticholinergic antipsychotics (like thioridazine or chlorpromazine) if you must use them, as they may worsen drug-induced delirium 3

Practical Implementation:

  • If seizure control is critical: Transition to an alternative antiepileptic (e.g., sodium valproate, as documented in case reports 4, 5) rather than continuing levetiracetam plus antipsychotics
  • If antipsychotic use is necessary for severe agitation: Use benzodiazepines preferentially over antipsychotics for drug-induced agitation 3, or select atypical antipsychotics with minimal anticholinergic effects (ziprasidone, risperidone) for brief periods only
  • Timeline expectation: Hallucinations should resolve within 2-14 days of levetiracetam discontinuation 1

The evidence is clear: levetiracetam-induced hallucinations are a medication adverse effect requiring medication adjustment, not a primary psychiatric condition requiring antipsychotic treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.